January 12, 2011

Sanofi-aventis Enters into Two Research & Development Collaborations with the University of California, San Francisco

 

Sanofi-aventis Enters into Two Research & Development Collaborations with the University of California, San Francisco

Paris, France – January 12, 2011 – Sanofi-aventis (EURONEXT: SAN and NYSE: SNY) and the University of California, San Francisco (UCSF) announced today that they have formed two research and development collaborations that join together leaders from academia and industry to more rapidly advance groundbreaking innovation from the lab to the patient. The first collaboration promotes innovative research in pharmacological science and in multiple therapeutic areas, such as oncology, aging, diabetes and inflammation. The second collaboration is an oncology partnership that will focus on project-based collaboration to accelerate the progression of research through the clinical proof of concept stage.